• OPEN AN ACCOUNT
Indian Indices
Nifty
24,750.90 130.70
(0.53%)
Sensex
82,096.43 654.39
( 0.80%)
Bank Nifty
55,760.85 84.00
( 0.15%)
Nifty IT
37,107.95 169.85
( 0.46%)
Global Indices
Nasdaq
42,322.33 -126.41
(-0.30%)
Dow Jones
5,957.59 -34.22
(-0.57%)
Hang Seng
37,687.53 133.04
(0.35%)
Nikkei 225
8,811.04 9.75
(0.11%)
Forex
USD-INR
85.85 0.27
(0.32%)
EUR-INR
97.86 0.31
(0.32%)
GBP-INR
116.24 0.53
(0.46%)
JPY-INR
0.60 0.00
(0.24%)

EQUITY - MARKET SCREENER

Solara Active Pharma Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541540
INE624Z01016
302.8807289
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SOLARA
0
2089.86
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Lypsa Gems & Jewellery reports consolidated net loss of Rs 15.28 crore in the March 2025 quarter
May 30,2025
Net Loss of Lypsa Gems & Jewellery reported to Rs 15.28 crore in the quarter ended March 2025 as against net loss of Rs 32.74 crore during the previous quarter ended March 2024. Sales rose 115.03% to Rs 6.58 crore in the quarter ended March 2025 as against Rs 3.06 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 15.17 crore in the year ended March 2025 as against net loss of Rs 32.71 crore during the previous year ended March 2024. Sales rose 75.87% to Rs 16.69 crore in the year ended March 2025 as against Rs 9.49 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales6.583.06 115 16.699.49 76
OPM %-231.61-1066.67 --89.75-341.73 -
PBDT-15.24-32.64 53 -14.98-32.43 54
PBT-15.30-32.70 53 -15.19-32.67 54
NP-15.28-32.74 53 -15.17-32.71 54